Zhen Yang

Zhen Yang

Auto-generated profile, based on publicly available information

Zhen Yang

Department of General Surgery, Minhang Hospital, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
LFLi Feng
Li Feng
JLJian Li
Jian Li
FLFan Li
Fan Li
HLHuanqin Li
Huanqin Li
SBSonghua Bei
Songhua Bei
ZYZhen Yang
Zhen Yang

5 June 2020 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
ZPZhiyu Pan
Zhiyu Pan
JDJunbin Ding
Junbin Ding
ZYZhen Yang
Zhen Yang
HLHuaqing Li
Huaqing Li
HDHongjian Ding
Hongjian Ding
QCQian Chen
Qian Chen
Background: Understanding the molecular mechanism of long non-coding RNAs (lncRNAs) in carcinogenesis is conducive for providing potential target for cancers. The role of FLVCR1-AS1 in breast cancer (BC) has not been probed yet. Materials and methods: qRT-PCR and western blot assays were used to estimate relevant expressions of mRNAs and proteins. CCK8, MTT and EdU were implemented to assess cell proliferation ability. TUNEL was performed to investigate cell apoptosis, whereas transwell assay was performed to test cell migration and invasion capacities. TOP/FOP Flash assay was conducted to determine the activity of Wnt/β-catenin pathway. Luciferase reporter, RNA pull down and RIP assays were performed to verify interaction between genes. Results: FLVCR1-AS1 was abnormally up-regulated in BC cells. Silencing FLVCR1-AS1 inhibited cell proliferation, migration, invasion, yet accelerating apoptosis. Inhibition of miR-381-3p reversed the tumor restraining impacts of FLVCR1-AS1 depletion on BC progression. Additionally, CTNNB1 was recognized to be targeted by miR-381-3p. FLVCR1-AS1 aggravated BC malignant progression via up-regulation CTNNB1 through sponging miR-381-3p. Conclusion: FLVCR1-AS1 regulates BC malignant behavior via sequestering miR-381-3p and then freeing CTNNB1, implying a promising target for BC therapy.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
HLHua-Qing Li
Hua-Qing Li
ZPZhi-Yu Pan
Zhi-Yu Pan
ZYZhen Yang
Zhen Yang
DZDon-Bing Zhang
Don-Bing Zhang
QCQian Chen
Qian Chen
Deep venous thrombosis (DVT) constitutes a great threat to health worldwide. Endothelial cell injury and dysfunction comprise the critical contributor for the development of DVT. However, the mechanism behind it remains poorly elucidated. The study is aimed at investigating the role of microRNA‐122 (miR‐122) and oxidative stress on DVT. The results showed that miR‐122 overexpression dampened H2O2‐evoked cytotoxic injury in human umbilical vein endothelial cells (HUVECs) by increasing cell viability, suppressing cell apoptosis and oxidative stress injury. Notably, miR‐122 overexpression attenuated provasoconstriction factor endothelin‐1 (ET‐1) expression in HUVECs exposed to H2O2 but enhanced the productions of vasodilatation factor Prostaglandin F1α (PGF1α). Moreover, inhibition of miR‐122 had the opposite results. miR‐122 could inhibit the expression of p53. Low expression of p53 could enhance the protection of miR‐122 on HUVEC injury. This study highlights that miR‐122 overexpression may restore H2O2‐induced HUVEC injury by regulating the expression of p53.